Lung dysfunction in diabetes

Diabetes Care

Volumn 26, Issue 6, 2003, Pages 1915-1918

  Goldman, Michael David ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE;

AIRWAY OBSTRUCTION; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG CAPACITY; LUNG COMPLIANCE; LUNG DISEASE; LUNG FUNCTION TEST; NOTE; OXYGEN TRANSPORT; PEAK EXPIRATORY FLOW; SMOKING; SPIROMETRY;

DIABETES COMPLICATIONS; HUMANS; LUNG DISEASES; RESPIRATORY FUNCTION TESTS;

EID: 0042168902     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.6.1915     Document Type: Note

References (41)

1. Schuyler M, Niewoehner D, Inkley S, Kohn R: Abnormal lung elasticity in juvenile diabetes mellitus. Am Rev Resp Dis 113:37-41, 1976
2. Schernthaner G, Haber P, Kummer F, Ludwig H: Lung elasticity in juvenile-onset diabetes mellitus. Am Re Respir Dis 116:544-546, 1977
3. Sandler M, Bunn A, Stewart R: Cross-section study of pulmonary function in patients with insulin- dependent diabetes mellitus. Am Rev Respir Dis 135:223-228, 1987
4. Strojek K, Ziora D, Sroczynskij, Oklek K: Pulmonary complications of type 1 (insulin-dependent) diabetic patients. Diabetologia 35:1173-1176, 1992
5. Innocenti F, Fabbri A, Anichini R, Tuci S, Pettina G, Vannucci F, De Giorgio LA, Seghieri G: Indications of reduced pulmonary function in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res Clin Pract 25:161-168, 1994
6. Schnack C, Festa A, Schwarzmaier-D'Assie A, Haber P, Schemthaner G: Pulmonary dysfunction in type 1 diabetes in relation to metabolic long-term control and to incipient diabetic nephropathy. Nephron 74:395-400, 1996
7. Asanuma Y, Fujiya S, Ide H, Agishi Y: Characteristics of pulmonary function in patients with diabetes mellitus. Diabetes Res Clin Pract 1:95-101, 1985
8. Mori H, Okubo M, Okamura M, Yamane K, Kado S, Egusa G, Hiramoto T, Hara H, Yamakido M: Abnormalities of pulmonary function in patients with non-insulin-dependent diabetes mellitus. Intern Med 31:189-193, 1992
9. Ljubic S, Metelko Z, Car N, Roglic G, Drazic Z: Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest 114:1033-1035, 1998
10. Isotani H, Nakamura Y, Kameoka K, Tanaka K, Furukawa K, Kitaoka H, Ohsawa N: Pulmonary diffusing capacity, serum angiotensin-converting enzyme activity and the angiotensin-converting enzyme gene in Japanese non-insulin-dependent diabetes mellitus patients. Diabetes Res Clin Pract 43:173-177, 1999
11. Marvisi M, Bartolini L, del Borrello P, Brianti M, Marani G, Guariglia A, Cuomo A: Pulmonary function in non-insulin-dependent diabetes mellitus. Respiration 68: 268-272, 2001
12. Sandler M: Is the lung a 'target organ' in diabetes mellitus? Arch Intern Med 150: 1385-1388, 1990
13. Matsubara T, Hara F: The pulmonary function and histopathological studies of the lung in diabetes mellitus. Nippon Ika Daigaku Zasshi 58:528-536, 1991
14. Fuso L, Cotroneo P, Basso S, De Rosa M, Manto A, Ghirlanda G, Pistelli R: Postural variations of pulmonary diffusing capacity in insulin-dependent diabetes mellitus. Chest 110:1009-1013, 1996
15. Ozmen B, Celik P, Yorgancioglu A, Ozmen D, Cok G: Pulmonary function parameters in patients with diabetes mellitus. Diabetes Res Clin Pract 57:209-211, 2002
16. Benbassat C, Stern E, Kramer M, Lebzelter J, Blum I, Fink G: Pulmonary function in patients with diabetes mellitus. Am J Med Sci 322:127-132, 2001
17. Davis T, Knuiman M, Kendall P, Vu H, Davis WA: Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract 50:153-159, 2000
18. Klein B, Moss S, Klein R, Cruickshanks K: Is peak expiratory flow rate a predictor of complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. J Diabetes Complications 15:301-306, 2001
19. Klein B, Moss S, Klein R, Cruickshanks K: Peak expiratory flow rate: relationship to risk variables and mortality: the Wisconsin Epidemiologic Study of diabetic retinopathy. Diabetes Care 24:1967-1971, 2001
20. Engstrom G, Janzon L: Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet Med 19:167-170, 2002
21. Mancini M, Filippelli M, Seghieri G, Iandelli I, Innocenti F, Duranti R, Scano G: Respiratory muscle function and hypoxic ventilatory control in patients with type I diabetes. Chest 115:1553-1562, 1999
22. Scano G, Seghieri G, Mancini M, Filippelli M, Duranti R, Fabbri A, Innocenti F, Iandelli I, Misuri G: Dyspnoea, peripheral airway involvement and respiratory muscle effort in patients with type I diabetes mellitus under good metabolic control. Clin Sci (Lond) 96:499-506, 1999
23. Scano G, Filippelli M, Romagnoli I, Mancini M, Misuri G, Duranti R, Rosi E: Hypoxic and hypercapnic breathlessness in patients with type I diabetes mellitus. Chest 117:960-967, 2000
24. Grimby G, Takishima T Graham W, Macklem P, Mead J: Frequency dependence of flow resistance in patients with obstructive lung disease. J Clin Invest 47: 1455-1465, 1968
25. Ingram R, O'Cain C: Frequency dependence of compliance in apparently healthy smokers versus nomsmokers. Bull Physiopath Respir 7:195-212, 1971
26. Cefalu W, Teeter J, Balagtas C, Gelfand R, Landschulz W: Sustained long-term efficacy and pulmonary safety of inhaled dry-powder insulin (Abstract). Am J Resp Grit Care Med 163:A163, 2001
27. Skyler J: Efficacy and safety of inhaled insulin (Exubera) compared to subcutaneous insulin: therapy in an intensive insulin regimen in patients with type 1 diabetes: results of a 6-month, randomized comparative trial (Abstract). Diabetes 51:A134, 2002
28. Morgan W, Reger R: Rise and fall of the FEV(1). Chest 118:1639-1644, 2000
29. Ford E: Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22:1971-1977, 1999
30. Rodriguez M, Guerrero R: Increased levels of C-reactive protein in non-controlled type 2 diabetic subjects. J Diabetes Complications 13:211-215, 1999
31. Tan K, Chow W, Tam S, Ai V, Lam C, Lam K: Atorvastatin lowers C-reactive protein and- improves endothelium-dependent vasodilation in type 2 diabetes mellitus. J Clin Endocrinol Metab 87:563-568, 2002
32. Barnes PJ: The role of inflammation and anti-inflammatory medication in asthma. Respir Med 96 (Suppl. A):S9-S15, 2002
33. Kjeldgaard J, Hyde R, Speers D, Reichert W: Frequency dependence of total respiratory resistance in early airway disease. Am Rev Respir Dis 144:501-508, 1976
34. Làndsér F, Clément J, Van De Woestijne K: Normal values of total respiratory resistance and reactance determined by forced oscillations: influence of smoking. Chest 81:586-591, 1982
35. Brochard L, Pelle G, de Palmas J, Brochard P, Carvie A, Lorino H, Harf A: Density and frequency-dependence of resistance in early airway obstruction. Am Rev Resp Dis 135:579-584, 1987
36. Goldman M, Knudson R, Mead J, Peterson N, Schwaber J, Wohl M: A simplified measurement of respiratory resistance by forced oscillations. J Appl Physiol 28:113-116, 1970
37. Goldman M: Clinical application of forced oscillation. Pulm Pharmacol Ther 14:341-350, 2001
38. Scheideler L, Manke H, Schwulera U, Inacker O, Hammerle H: Detection of nonvolatile macromolecules in breath. A possible diagnostic tool? Am Rev Respir Dis 148:778-784, 1993
39. Montuschi P, Collins J, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, Barnes PJ: Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 162:1175-1177, 2000
40. Becher G, Winsel K, Beck E, Neubauer G, Stresemann E: Breath condensate as a method of noninvasive assessment of inflammation mediators from the lower airways. Pneumologie 52:456-459, 1997
41. Hashimoto Y, Nakahara K: Improvement of asthma after administration of pioglitazone (Letter). Diabetes Care 25:401, 2002